Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans.
Azoles (imidazoles and triazoles) are used as antifungal agents in agriculture and in medicine, and also for antiestrogen therapy, e.g., for breast cancer treatment. Antifungal activity is based on inhibition of fungal CYP51 (lanosterol 14alpha-demethylase), and estrogen biosynthesis reduction is due to azole inhibition of CYP19 (aromatase). Inhibition of aromatase by antifungal agents is usually an unwanted side effect and may cause endocrine disruption. A fluorimetric assay based on human recombinant CYP19 enzyme with dibenzylfluorescein as a substrate was used to compare the inhibitory potency of 22 azole compounds. Dose responses were established and duplicate datasets were analyzed with a nonlinear mixed-effects model with cumulative normal distribution for the logarithm of concentration. IC50 values (50% inhibitory concentration) of 13 fungicides used in agriculture ranged more than 700-fold, starting from 0.047 microM. The potency of seven human drugs spanned more than 7000-fold, starting from 0.019 microM. Most potent fungicides included prochloraz, flusilazole, and imazalil, and most potent medicinal antifungals were bifonazole, miconazole, and clotrimazole. These in vitro data indicate that the top-ranking azoles used as antifungal agents or drugs are as potent inhibitors of aromatase as are antiestrogen therapeutics used to treat breast cancer. These putative effects of azole agents and drugs on steroid biosynthesis and sex hormone balance should be considered when used in human subjects and also in wildlife exposed to azole fungicides used in agriculture.
Trösken
Eva R
ER
Department of Toxicology, University of Würzburg, Würzburg, Germany.
Scholz
Karoline
K
Lutz
Roman W
RW
Völkel
Wolfgang
W
Zarn
Jürg A
JA
Lutz
Werner K
WK
D016573:Agrochemicals / Q000737:chemistry / Q000494:pharmacology*; D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology*; D018931:Antineoplastic Agents, Hormonal / Q000737:chemistry / Q000145:classification / Q000494:pharmacology; D001141:Aromatase / Q000187:drug effects*; D047072:Aromatase Inhibitors / Q000737:chemistry / Q000145:classification / Q000494:pharmacology*; D001393:Azoles / Q000737:chemistry / Q000145:classification / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects; D020847:Estrogen Receptor Modulators / Q000737:chemistry / Q000145:classification / Q000494:pharmacology; D005656:Fungal Proteins / Q000187:drug effects; D005659:Fungicides, Industrial / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000737:chemistry / Q000145:classification / Q000494:pharmacology; D020128:Inhibitory Concentration 50; D016015:Logistic Models; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000145:classification; D011994:Recombinant Proteins; D014230:Triazoles / Q000737:chemistry / Q000145:classification / Q000494:pharmacology
D016573:Agrochemicals; D000935:Antifungal Agents; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D001393:Azoles; D020847:Estrogen Receptor Modulators; D005656:Fungal Proteins; D005659:Fungicides, Industrial; D007093:Imidazoles; D004364:Pharmaceutical Preparations; D011994:Recombinant Proteins; D014230:Triazoles; D003577:Cytochrome P-450 Enzyme System; D001141:Aromatase